Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1991-06-04
1995-01-03
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514315, 514397, 514406, 514415, 514424, 514461, 514468, 514486, 546292, 5483714, 548245, 564148, 564152, 564154, A61K 31535, A61K 31445, C07D21172, C07D26104
Patent
active
053787293
ABSTRACT:
The present invention relates to compounds exhibiting central nervous system (CNS) activity which are useful in the treatment of epilepsy and other CNS disorders. The compounds of this invention have the following general formula: ##STR1## and pharmaceutically acceptable salts thereof.
REFERENCES:
patent: 2676188 (1954-04-01), Bruce et al.
patent: 2721197 (1955-10-01), Sheehan
patent: 3340147 (1967-09-01), Martin et al.
patent: 3657341 (1972-04-01), Thorne et al.
patent: 3707559 (1972-12-01), Mazur et al.
patent: 4018826 (1977-04-01), Gless, Jr. et al.
patent: 4260684 (1981-04-01), Schult
patent: 4303673 (1981-12-01), Biedermann et al.
patent: 4513009 (1985-04-01), Roques et al.
patent: 4595700 (1986-06-01), Donald et al.
patent: 4618708 (1986-10-01), Roques et al.
patent: 4873241 (1989-10-01), Napier et al.
Chemical Abstracts, vol. 92; No. 7:51712r (Feb. 18, 1990).
Chemical Abstracts, vol. 96; No. 5:35710r (Feb. 1, 1982).
Chemical Abstracts, vol. 101; No. 9; 72124v (Aug. 27, 1984).
Chemical Abstracts, vol. 91; No. 21:175147; (Nov. 19, 1979).
Kohn, et al. (1988) Brain Research 457: 371-375, Marked Sterospecificity in a New Class of Anticonvulsants.
Chemical Abstracts, vol. 97; 145266d (1982).
White, et al. (1981) JACS, 103:4231-4239, Active-Site-Directed Inhibition of alpha-Chymotrypsin by Deaminatively Produced Carbonium Ions: An Example of Suicide of Enzyme-Activated-Substrate Inhibition.
Legall, et al. (1988) Int. J. Protein Res., 12:279-291 Synthesis of Functionalized Non-Natural Amino Acid Derivatives via Amidoalkylation Transformations.
Conley, et al. (1987) J. Med. Chem., 30(3):574-580, Functionalized DL-Amino Acid Derivatives, Potent New Agents for the Treatment of Epilepsy.
Garcia, et al. (1984) Tetrahedron Letters, 25(42) 4841-4844, New Synthetic "Tricks" Triphenylphosphine-Mediated Amide Formation from Carboxylic Acids and Azides.
Rebek, et al. (1979), J. Am. Chem. Soc., 101(3):737, On the Rate of Site-Site Interactions in Functionalized Polystyrenes.
Cortes, et al. (1985) J. Med. Chem., 28:601-606, Effect of Structural Modification of the Hydantion Ring on Anticonvulsant Activity.
Ikeda, et al. (1977) Tetrahedron, 33(5): 489-495, Photochemical Synthesis of 1,2,3,4-Tetrahydroisoquinolin-3-ones from N-Chloroacetylbenzylamines.
Katritzky, et al. (1990) J. Org. Chem. 55: 2206-2214, Benzotriazole-Assisted Synthesis of Monoacyl Animals and Their Peptide Derivatives.
Lipshutz et al. (1983) J. Am. Chem. Soc. 105; 7703-7713, Heterocycles as Masked Diamide/Dipeptide Equivalents, Formation and Reactions of Substituted 5-(Acylamino) Oxazoles as Intermediates en Route to the Cyclopeptide Alkaloids.
Lipshutz et al. (1983) J. Org. Chem. 48:3745-3750, An Approach to the Cyclopeptide Alkaloids (Phenylcyclopeptines) via Heterocyclic Diamide/Dipeptide Equivalents, Preparation and N-Alkylation Studies of 2,4(5)-Disubstituted Imidazoles.
Rogues, (1987) 193rd ACS National Meeting Amer. Chem. Society, Apr. 15-10, 1987, Use of Various Metallopeptidase Inhibitors to Study the Physilogical Rate of Endogenous Neuropeptides.
Kohn, et al. (1990) J. Med Chem. 33:919-926, Preparation and Anticonvulsant Activity of a Series of Functionalized .beta.-Aromatic and .alpha. Heteroaromatic Amino Acids.
Lipshutz et al. "Heterocycles in Synthesis . . . Imidazoles" Journal of the American Chemical Society, vol. 106, No. 2, pp. 457-459 CA 102(19): 160030n (1985).
Kohn Harold L.
Watson Darrell
Cintins Marianne M.
Criares T.
Research Corporation Technologies Inc.
LandOfFree
Amino acid derivative anticonvulsant does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amino acid derivative anticonvulsant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amino acid derivative anticonvulsant will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2211886